WVE Q2 2023 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$22M+5794.9% YoY

Gross Profit

-$11M-50.7% margin

Operating Income

-$23M-106.2% margin

Net Income

-$21M-95.5% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

+71.0%

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$37M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$230M

Total Liabilities

$282M

Stockholders' Equity

-$52M

Cash & Equivalents

$173M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$375,000	+5794.9%
Gross Profit	-$11M	-$29M	+61.8%
Operating Income	-$23M	-$42M	+44.3%
Net Income	-$21M	-$41M	+48.9%